OVID Dividend: Ovid Therapeutics Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

OVID Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	6	0	0	1	208	12
Revenue Growth (YoY)	--	--	-100%	-100%	1,632.99%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	22	25	31	32	37	30
Research & Development	24	36	28	24	46	63
Operating Expenses	47	62	59	57	84	94
Other Non Operating Income (Expenses)	4	30	--	--	--	--
Pretax Income	-36	-26	-52	-54	124	-81
Income Tax Expense	0	0	--	0	1	--
Net Income	-36	-26	-52	-54	119	-81
Net Income Growth	13%	-50%	-4%	-145%	-247%	35%
Shares Outstanding (Diluted)	71.11	70.9	70.58	70.4	68.1	58.5
Shares Change (YoY)	0%	0%	0%	3%	16%	49%
EPS (Diluted)	-0.51	-0.37	-0.74	-0.77	1.76	-1.39
EPS Growth	11%	-50%	-4%	-144%	-227%	-10%
Free Cash Flow	-37	-56	-45	-56	118	-52
Free Cash Flow Per Share	-0.52	-0.78	-0.63	-0.79	1.73	-0.88
Gross Margin	--	--	--	--	--	--
Operating Margin	-666.66%	0%	0%	-5,500%	59.61%	-675%
Profit Margin	-600%	0%	0%	-5,400%	57.21%	-675%
Free Cash Flow Margin	-616.66%	0%	0%	-5,600%	56.73%	-433.33%
EBITDA	-40	-61	-58	-55	124	-81
EBITDA Margin	-666.66%	0%	0%	-5,500%	59.61%	-675%
D&A For EBITDA	0	0	1	0	0	0
EBIT	-40	-61	-59	-55	124	-81
EBIT Margin	-666.66%	0%	0%	-5,500%	59.61%	-675%
Effective Tax Rate	0%	0%	--	0%	0.8%	--